PHIO Stock Performance, Insider Transaction and News

PHIO - Phio Pharmaceuticals Corp.

Market Cap	4.58M	P/E	-	EPS this Y	30.70%	Ern Qtrly Grth	-
Income	-10.83M	Forward P/E	0.13	EPS next Y	-	50D Avg Chg	-18.00%
Sales	-	PEG	-	EPS past 5Y	-	200D Avg Chg	-48.00%
Dividend	N/A	Price/Book	0.40	EPS next 5Y	-	52W High Chg	-79.00%
Recommedations	-	Quick Ratio	5.20	Shares Outstanding	4.59M	52W Low Chg	3.00%
Insider Own	0.59%	ROA	-59.86%	Shares Float	4.56M	Beta	1.42
Inst Own	11.04%	ROE	-116.60%	Shares Shorted/Prior	33.83K/176.63K	Price	2.53
Gross Margin	-	Profit Margin	-	Avg. Volume	501,104	Target Price	4.00
Oper. Margin	-	Earnings Date	May 9	Volume	36,034	Change	-5.60%

Healthcare | Biotechnology | United States

About Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. The company develops PH-762, INTASYL compound which reduces the expression of cell death Protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; PH-894 that silences the BRD4, a protein which controls gene expression in both T cells and tumor cells, effecting the immune system as well as the tumor; and PH-804 that targets the TIGIT, a protein which inhibits the activity of Natural Killer cells. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.

Phio Pharmaceuticals Corp. News

04/22/24	Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells
04/16/24	Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)
04/11/24	Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
04/03/24	National Spotlight Features Phio’s Innovative RNAi Technology Platform
04/02/24	Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
03/21/24	Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
03/13/24	Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research
03/06/24	Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders
01/31/24	Phio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
12/07/23	Phio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross Proceeds
11/09/23	Phio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
11/09/23	Phio Pharmaceuticals Announces First US Patient Enrolled in Phase 1B Clinical Trial with Intratumoral PH-762 anti-PD-1 Therapy for Treatment of Skin Carcinomas
11/03/23	Phio Pharmaceuticals Presents New Data Showing INTASYL Compound targeting CTLA-4 Enhances Tumor Control
10/12/23	PHIO Jumps 91% on Encouraging Preclinical Cancer Drug Data
10/12/23	Phio Pharmaceuticals Announces Upcoming Presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
10/11/23	Phio Pharmaceuticals Presents New Data for Targeting of BRD4 with its INTASYL™ Compound PH-894
09/06/23	Phio CEO to Speak at Wainwright Conference in New York in September
08/21/23	Phio Pharmaceuticals Announces Dosing of First Patient in Collaborative Clinical Trial with AgonOx, Inc. and Providence Cancer Institute
08/10/23	Phio Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
06/02/23	Phio Pharmaceuticals Announces Closing of $4 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules

PHIO Chatroom

StocksSchmocks Posted - 1 day ago

$PHIO averaged down and sitting green here. This looks to be headed back above .95+ It may take awhile or it might be next week. Decent uptrend and a good PR will send it. I'll sit here until it does, with a trailing stop to keep losses minimal.

Stayou Posted - 1 day ago

$PHIO The management doesn't care about shareholders at all. We're happy to Lose, as long as we pay for their Jobs.

DosGatos Posted - 2 days ago

$PHIO Not adding on dips!

Stonkey Posted - 2 days ago

$PHIO Yes, @Zeit59.....it's true li'l buddy.

theflynews Posted - 2 days ago

Biotech Alert: Searches spiking for these stocks today - $PHIO - https://thefly.com/permalinks/entry.php/PHIOid3902481

MarketMasterMind Posted - 2 days ago

$PHIO adding on dips 🤑Ⓜ️

Zeit59 Posted - 3 days ago

$PHIO they are successful pioneers in RNA technology and the founder received a Nobel Prize nearly 20 years ago on discovering the whole field. Here is a copy of yesterday’s announcement which spurred the 75% spike. https://s3.amazonaws.com/b2icontent.irpass.cc/2839/rl133443.pdf I believe it will go back up. Maybe not tomorrow but soon. They’re way ahead of their competitors in the field of mRNA studies tackling cancer. Back over a dollar again before long.

DosGatos Posted - 3 days ago

$PHIO

Stonkey Posted - 3 days ago

$PHIO Today it's a POS scam, and yesterday too.

Zeit59 Posted - 3 days ago

$PHIO is ridiculously volatile. Yesterday it was everybody’s dream child. Today people are dumping them. Stupid market. I didn’t buy it to day trade it. Sucks. But it will probably go up again next year 😂

NoStlye79 Posted - 3 days ago

$MLEC $PHIO watch from no movement PM to beat yesterday's HOD.. The low float sleeper today

Pukkaa56 Posted - 3 days ago

$PHIO old announcement

Marconi_I_play_the_momba Posted - 3 days ago

$PHIO https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-reverse-stock-split-301729845.html

Stayou Posted - 3 days ago

$PHIO on the phio HP there is another reverse split announced!!!

ChasingTrades Posted - 3 days ago

$PHIO nice trade here yesterday, watching today again 🤭

Stayou Posted - 3 days ago

$PHIO i can't believe it: Another reverse split. When will they be removed? Go to hell!!

DaDisciplinedTrader Posted - 4 days ago

$PHIO no gap on the daily but still fails to hold key so called support levels. Already has given back half of today's gains in the after hours alone. Literally pump and dumps even with a solid catalysts. Welcome to Wallstreet

Billionscash Posted - 4 days ago

$PHIO today announced its INTASYL platform will be the focus of Viewpoint, a national program hosted by Dennis Quaid. The program will air in April on PBS stations across the country. The spotlight will also be featured nationally on Fox Business Network on April 24th, and regionally on a number of networks, including CNN and MSNBC, throughout the month of April

MKRReformed Posted - 4 days ago

$AGBA 🫡 $phio .76-1.05 call for potential 38% win $gbr holding some red 1.36 avg now. Relatively small position $mysz 1/8 restructure tmrw, potential float abuse play

nateboyd Posted - 4 days ago

$PHIO just grabbed some more

DaDisciplinedTrader Posted - 4 days ago

$PHIO good ole wallstreet

Finnisher2M Posted - 4 days ago

$PHIO 🔥Overnight 0.79🤞🔥

timelesstrades Posted - 4 days ago

$PHIO expect a private placement around 30 to 40 mil

BearishAlgo Posted - 4 days ago

Today's short setups results $KA $VIVK $PHIO $ZCAR

timelesstrades Posted - 4 days ago

$PHIO she’s gonna take off

nateboyd Posted - 4 days ago

$PHIO could of sold and reloaded but I missed the opportunity. I'm not giving the shares away for no 10% tho

timelesstrades Posted - 4 days ago

$PHIO I’m not in this, but it seems like this is about to takeoff.

frankyboyz Posted - 4 days ago

$phio lol that was a fast bounce lmao thank u

StocksSchmocks Posted - 4 days ago

$PHIO added

VrtcIl Posted - 4 days ago

Float Rotation $PHIO made a new shares rotation (count: 1). Elevated volatility on this one. Adjust your stops according to this greater volatility. Spikes to the long and the short side are possible. Gain: 10.9% Float: 2.4M Short Float: 7.4 %

Analyst Ratings

HC Wainwright & Co.	Buy	Feb 6, 24
HC Wainwright & Co.	Buy	Aug 16, 23

Insider Trades	Relationship	Date	Transactions	Cost($)	#Shares	Value($)	#Share Own	SEC Form 4
Ferrara Robert L	Director Director	Jun 14	Buy	3.10	2,000	6,200	6,000	06/15/23
Bitterman Robert J	Interim Executive Ch.. Interim Executive Chairman	Dec 14	Buy	0.39	2,000	780	74,541	12/15/22
Bitterman Robert J	Interim Executive Ch.. Interim Executive Chairman	Dec 05	Buy	0.43	2,000	860	70,541	12/06/22
Bitterman Robert J	Interim Executive Ch.. Interim Executive Chairman	Nov 25	Buy	0.41	2,715	1,113	68,541	11/29/22
Ferrara Robert L	Director Director	Nov 23	Buy	0.4099	2,000	820	25,000	11/28/22
Bitterman Robert J	Interim Executive Ch.. Interim Executive Chairman	Nov 16	Buy	1750.00	1	1,750	1	11/16/22